Working together with Swedish Orphan Biovitrum to distribute orphan status medicines in Switzerland through their German sub-contractor. This includes the distribution of low volume cold chain shipments that require cost efficient and reliable solutions to ensure accessibility
Working with Ipsen Europe to distribute as unregistered product Cabometyx for selected Swiss patients on the treatment. Organizing the import permits and corresponding with the health insurance to ensure that the treatment arrives safely and securely for the patient.
Health insurance company in Latin American required for patients the product Jinarc by Otsuka. Working directly with the manufacturer and organizing the doctor approval, patient file and import permit, Jinarc has been successfully supplied for the patient to start their treatment.